SHARE
COPY LINK

HEALTH

Italy to be first EU country to make Russian Sputnik vaccine

An Italian-Swiss pharmaceutical company has agreed to produce Russia's Sputnik V vaccine in Italy, the first such deal in the European Union, a trade body said on Tuesday.

Italy to be first EU country to make Russian Sputnik vaccine
Russia's Sputnik V vaccine is to be produced in Italy by summer. Photo: Norberto Duarte/AFP

An Italian-Swiss pharmaceutical company has agreed to produce Russia’s Sputnik V vaccine in Italy, the first such deal in the European Union, a trade body said Tuesday.

“The vaccine will be produced from July 2021 in (pharma company) Adienne factories in Lombardy,” northern Italy, a spokesman for the Italian-Russian Chamber of Commerce, Stefano Maggi, told AFP.

“Ten million doses will be produced between July 1 and January 1, 2022,” he added, describing it as the “first agreement on the European level for the production on EU territory of the Sputnik vaccine”.

Several European Union countries have already begun distributing Sputnik V, but it has yet to be approved by the bloc’s medicines regulator, the European Medicines Agency (EMA).

Last week the Amsterdam-based EMA launched a rolling review of the Sputnik V vaccine, a key step towards being approved as the first non-Western jab to be used against the coronavirus across the 27-nation bloc.

“If the vaccine is not authorised in Europe by July 1, the doses produced (in Italy) will be bought by the Russian sovereign fund and distributed in countries where the Sputnik vaccine is authorised,” Maggi said.

Italy’s health ministry, contacted by AFP, declined to comment on the deal, while Adienne was not immediately available.

READ ALSO: 

The EU has so far authorised three vaccines: the US-German Pfizer/BioNTech jab, US firm Moderna’s shot, and the British-Swedish AstraZeneca/Oxford vaccine.

It is set to decide on the one-shot Johnson & Johnson vaccine on March 11, while jabs by Novavax and CureVac are also under rolling review.

Sputnik has been approved in 46 countries outside Europe.

According to medical journal The Lancet, the Sputnik vaccine is 91.6% effective against symptomatic forms of the Covid-19 disease.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

HEALTH

Italy reports first case of monkeypox

Italy on Thursday reported its first case of monkeypox, joining a number of other European and North American nations in detecting the disease endemic in parts of Africa.

Italy reports first case of monkeypox

Monkeypox was identified in a young adult who had recently returned from the Canary Islands, Rome’s Spallanzani Institute for infectious diseases said.

He is being treated in isolation and is in a reasonable condition, it said in a statement carried by Italian news agencies, adding that two other suspected cases were being investigated.

Alessio D’Amato, health commissioner for the Lazio region that includes Rome, confirmed on social media that it was the country’s first case, adding that the situation was being “constantly monitored”.

Cases of monkeypox have also been detected in Spain and Portugal – where more than 40 possible and verified cases have been reported – as well as Britain, Sweden, the United States and Canada.

The illness has infected thousands of people in parts of Central and Western Africa in recent years, but is rare in Europe and North Africa.

Its symptoms are similar but somewhat milder than smallpox’s: fever, headache, muscle aches, back pain, chills, exhaustion, although it also causes the lymph nodes to swell up.

Within one to three days, the patient develops a rash, often beginning on the face then spreading to other parts of the body. Although most monkeypox cases aren’t serious, studies have shown that one in ten people who contract the disease in Africa die from it.

The World Health Organization on Tuesday said it was coordinating with UK and European health officials over the new outbreaks.

SHOW COMMENTS